40
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The Warburg effect describes how cancer cells down-regulate their aerobic respiration and preferentially use glycolysis to generate energy. To evaluate the link between hypoxia and Warburg effect, we studied mitochondrial electron transport, angiogenesis and glycolysis in pheochromocytomas induced by germ-line mutations in VHL, RET, NF1 and SDH genes. SDH and VHL gene mutations have been shown to lead to the activation of hypoxic response, even in normoxic conditions, a process now referred to as pseudohypoxia. We observed a decrease in electron transport protein expression and activity, associated with increased angiogenesis in SDH- and VHL-related, pseudohypoxic tumors, while stimulation of glycolysis was solely observed in VHL tumors. Moreover, microarray analyses revealed that expression of genes involved in these metabolic pathways is an efficient tool for classification of pheochromocytomas in accordance with the predisposition gene mutated. Our data suggest an unexpected association between pseudohypoxia and loss of p53, which leads to a distinct Warburg effect in VHL-related pheochromocytomas.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: found

          TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis

          The p53 tumor-suppressor protein prevents cancer development through various mechanisms, including the induction of cell-cycle arrest, apoptosis, and the maintenance of genome stability. We have identified a p53-inducible gene named TIGAR (TP53-induced glycolysis and apoptosis regulator). TIGAR expression lowered fructose-2,6-bisphosphate levels in cells, resulting in an inhibition of glycolysis and an overall decrease in intracellular reactive oxygen species (ROS) levels. These functions of TIGAR correlated with an ability to protect cells from ROS-associated apoptosis, and consequently, knockdown of endogenous TIGAR expression sensitized cells to p53-induced death. Expression of TIGAR may therefore modulate the apoptotic response to p53, allowing survival in the face of mild or transient stress signals that may be reversed or repaired. The decrease of intracellular ROS levels in response to TIGAR may also play a role in the ability of p53 to protect from the accumulation of genomic damage.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            p53 regulates mitochondrial respiration.

            The energy that sustains cancer cells is derived preferentially from glycolysis. This metabolic change, the Warburg effect, was one of the first alterations in cancer cells recognized as conferring a survival advantage. Here, we show that p53, one of the most frequently mutated genes in cancers, modulates the balance between the utilization of respiratory and glycolytic pathways. We identify Synthesis of Cytochrome c Oxidase 2 (SCO2) as the downstream mediator of this effect in mice and human cancer cell lines. SCO2 is critical for regulating the cytochrome c oxidase (COX) complex, the major site of oxygen utilization in the eukaryotic cell. Disruption of the SCO2 gene in human cancer cells with wild-type p53 recapitulated the metabolic switch toward glycolysis that is exhibited by p53-deficient cells. That SCO2 couples p53 to mitochondrial respiration provides a possible explanation for the Warburg effect and offers new clues as to how p53 might affect aging and metabolism.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity.

              Many cancer cells are characterized by increased glycolysis and decreased respiration, even under aerobic conditions. The molecular mechanisms underlying this metabolic reprogramming are unclear. Here we show that hypoxia-inducible factor 1 (HIF-1) negatively regulates mitochondrial biogenesis and O(2) consumption in renal carcinoma cells lacking the von Hippel-Lindau tumor suppressor (VHL). HIF-1 mediates these effects by inhibiting C-MYC activity via two mechanisms. First, HIF-1 binds to and activates transcription of the MXI1 gene, which encodes a repressor of C-MYC transcriptional activity. Second, HIF-1 promotes MXI-1-independent, proteasome-dependent degradation of C-MYC. We demonstrate that transcription of the gene encoding the coactivator PGC-1beta is C-MYC dependent and that loss of PGC-1beta expression is a major factor contributing to reduced respiration in VHL-deficient renal carcinoma cells.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS One
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, USA )
                1932-6203
                2009
                18 September 2009
                : 4
                : 9
                : e7094
                Affiliations
                [1 ]INSERM, unit 970, Paris, France
                [2 ]Collège de France, Paris, France
                [3 ]Université Paris Descartes, Faculté de Médecine, Paris, France
                [4 ]Paris-Cardiovascular research Center at HEGP, Paris, France
                [5 ]INSERM, unit 676, Hôpital Robert Debré, Paris, France
                [6 ]Université René Diderot, Faculté de Médecine, Paris, France
                [7 ]Programme Cartes d'Identité des Tumeurs, Ligue Nationale Contre Le Cancer, Paris, France
                [8 ]AP-HP, Hôpital Cochin, Département d'Endocrinologie, Paris, France
                [9 ]AP-HP, Hôpital Européen Georges Pompidou, Service d'Anatomo-pathologie, Paris, France
                [10 ]AP-HP, Hôpital Cochin, Service d'Anatomie pathologique, Paris, France
                [11 ]AP-HP, Hôpital Européen Georges Pompidou, Service d'Hypertension artérielle, Paris, France
                [12 ]AP-HP, Hôpital Européen Georges Pompidou, Département de Génétique, Paris, France
                [13 ]Rare Adrenal Cancer Network-Corticomédullosurrénale Tumeur Endocrine, Institut National du Cancer, Paris, France
                City of Hope Medical Center, United States of America
                Author notes

                Conceived and designed the experiments: JF PR APGR. Performed the experiments: JJB NB PB PR. Analyzed the data: JF JJB LV AdR XJ PR APGR. Contributed reagents/materials/analysis tools: JB CB FT LA RL PFP APGR. Wrote the paper: JF PR APGR.

                Article
                09-PONE-RA-10200R2
                10.1371/journal.pone.0007094
                2738974
                19763184
                124f3181-e626-43aa-81f7-7061b4a31537
                Favier et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
                History
                : 7 May 2009
                : 20 August 2009
                Page count
                Pages: 12
                Categories
                Research Article
                Molecular Biology
                Diabetes and Endocrinology/Adrenal Cortex
                Oncology/Adrenal Cortex

                Uncategorized
                Uncategorized

                Comments

                Comment on this article